CHME...bunky, Including all warrants and options at the 19.6M share count, CHME still earned $0.125 a share. The share price is approx $2.50. The stock looks undervalued. They have a new weight loss product hitting the US market and another new product hitting the Pakistani market!! They're expecting 93%+ gross margins on their rADTZ product at approx $50 to $70 per tonne of feed. This should add good profits to the already good profits!
Also, the $39B feed market mentioned in todays PR is referring to the China market only. Looks like this could eventually go worldwide...
"The Company has applied for rADTZ patents in 13 different jurisdictions in 2007 (including Australia, Canada, the European Union, Indonesia, Israel, Japan, South Korea, Mexico, Russia, South Africa, the U.S., Hong Kong and India)."
Not sure what you mean by not quite as promising?
News 
Market Data 
Discover 
